Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province

Li ZHANG; Ying ZHANG; Xueya ZHANG; Zhuo YU

Article Contents

Article Navigation > Journal of Kunming Medical University > 2025 > Uncorrected proof

Li ZHANG, Ying ZHANG, Xueya ZHANG, Zhuo YU. Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province[J]. Journal of Kunming Medical University.

Citation:

PDF( 1323 KB)

Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province

Li ZHANG¹,
Ying ZHANG^{2, 3},
Xueya ZHANG^{2, 3, 4
,
,},
Zhuo YU^{3, 4, 5
,
,}

1.
School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products，Kunming Medical University，Kunming Yunan 650500
2.
Department of Traditional Chinese Medicine，The First Affiliated Hospital of Kunming Medical University，Kunming Yunan 650500
3.
Yunnan Provincial Specialized Committee on Collaterals Disease Studies，Kunming Yunnan 650032
4.
Cardiovascular Disease Specialty Committee of Yunnan Provincial Medical Association，Kunming Yunnan 650032
5.
Department of Cardiology，The First Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032，China

Received Date: 2025-03-04

Abstract

FullText(HTML)

References(147)

References

[1]	Vrints C, Andreotti F, Koskinas K C, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes[J]. Eur Heart J, 2024, 45(36): 3415-537. doi: 10.1093/eurheartj/ehae177
[2]	吴勉华, 石岩. 中医内科学[M]. 北京: 中国中医药出版社, 2021.
[3]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 慢性稳定性心绞痛诊断与治疗指南[J]. 中华心血管病杂志, 2007, 35(3): 195-206. doi: 10.3760/j.issn:0253-3758.2007.03.002
[4]	中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680‑694.
[5]	Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-77. doi: 10.1093/eurheartj/ehz425
[6]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国慢性冠脉综合征患者诊断及管理指南[J]. 中华心血管病杂志, 2024, 52(6): 589-614. doi: 10.3760/cma.j.cn112148-20240325-00168
[7]	中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(07): 625-660.
[8]	王吉耀, 葛均波, 邹和建. 实用内科学[M]. 第16版. 人民卫生出版社, 2022: 833-845.
[9]	Libby P. The changing landscape of atherosclerosis. Nature, 2021, 592 （7855）: 524 -533. Libby P. The changing landscape of atherosclerosis. Nature, 2021, 592 (7855): 524 -533.
[10]	王吉耀, 葛均波, 邹和建. 实用内科学[M]. 第16版. 人民卫生出版社, 2022: 833-845.
[11]	罗欢, 朱维, 樊瑞娟, 等. CTA在慢性冠脉综合征患者中作为首选检查方法的临床价值[J]. 江苏医药, 2025, 51(4): 329-334+340.
[12]	Van Belle E, Rioufol G, Pouillot C, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry[J]. Circulation, 2014, 129(2): 173‑185.
[13]	Koo B K, Hu X, Kang J, et al. Fractional flow reserve or intravascular ultrasonography to guide PCI[J]. N Engl J Med, 2022, 387(9): 779‑789.
[14]	文凤, 赵健. 秋水仙碱治疗冠状动脉粥样硬化性心脏病的研究进展[J]. 国际心血管病杂志, 2024, 51(6): 329-333. doi: 10.3969/j.issn.1673-6583.2024.06.001
[15]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 经皮冠状动脉介入治疗指南(2025)[J]. 中华心血管病杂志, 2025, 53(7): 16-44.
[16]	梁媛媛, 彭鑫, 毛黎黎, 等. 血府逐瘀汤对冠心病不稳定型心绞痛痰浊痹阻型Lp-PLA2、MCP-1、sICAM-1、炎性因子及生存质量的影响分析[J]. 中华中医药学刊, 2025, 43(1): 222-226.
[17]	吴剑宏, 陈幸谊. 血府逐瘀汤方剂的现代药理研究进展[J]. 中成药, 2013, 35(05): 1054-1058.
[18]	邓雅文. 基于网络药理学和转录组测序的血府逐瘀汤治疗冠心病的机制研究[D]. 中国中医科学院, 2020.
[19]	常培学, 李海波, 许振培. 银杏叶联合尼可地尔对药物洗脱支架治疗后老年冠心病患者多支病变的疗效分析[J]. 中华老年心脑血管病杂志, 2020, 22(03): 265-268.
[20]	冯锦辉, 毛祥正, 贺燕玲, 等. 银杏叶对心脑血管疾病药理作用的研究进展[J]. 陕西中医药大学学报, 2024, 47(5): 136-140.
[21]	冠心病稳定型心绞痛中医诊疗指南[J]. 中医杂志, 2019, 60(21): 1880-1890.
[22]	贾敏, 梁晓, 付国静, 等. 血塞通软胶囊临床应用专家共识[J]. 中国中药杂志, 2023, 48(20): 5668-5674.
[23]	霍勇, 吴宗贵, 林谦. 通心络防治冠心病临床应用中国专家共识[J]. 中国介入心脏病学杂志, 2024, 32(4): 181-190. doi: 10.3969/j.issn.1004-8812.2024.04.001
[24]	王阶, 赵涛, 熊兴江, 等. 丹红注射液治疗冠心病的作用机制与临床疗效[J]. 中国实验方剂学杂志, 2019, 25(24): 173-178.
[25]	安冬青, 吴宗贵. 动脉粥样硬化中西医结合诊疗专家共识[J]. 中国全科医学, 2017, 20(5): 507-511.
[26]	刘红旭, 吴永健, 王显, 等. 经皮冠状动脉介入治疗围手术期心肌损伤中医诊疗专家共识[J]. 中国中西医结合杂志, 2017, 37(4): 389-393.
[27]	付长庚, 刘龙涛, 王跃飞, 等. 丹红注射液临床应用中国专家共识[J]. 中国中西医结合杂志, 2018, 38(4): 389-397.
[28]	陈寅萤, 李华, 吴萍, 等. 丹红注射液治疗心脑血管疾病的药理作用机制研究进展[J]. 中国实验方剂学杂志, 2021, 27(15): 188-196.
[29]	陈静, 陶永, 戴小华, 等. 注射用丹参多酚酸盐治疗冠心病心绞痛的疗效观察[J]. 广州中医药大学学报, 2023, 40(5): 1070-1076.
[30]	王彦, 陈加容, 安闵生, 等. 丹参多酚酸盐治疗老年冠心病心绞痛疗效及对血脂代谢、血流动力学和心肌谱酶水平的影响[J]. 中华中医药学刊, 2021, 39(2): 199-202.
[31]	张书萌, 张湘卓, 曾雪芹, 等. 柴胡疏肝散加减治疗冠心病心绞痛疗效的Meta分析[J]. 湖南中医药大学学报, 2020, 40(7): 867-871.
[32]	刘英杰, 陈东, 孔晶. 加味柴胡疏肝散治疗气滞血瘀型稳定性心绞痛临床疗效及对血管内皮功能和心肌能量代谢的影响[J]. 河北中医, 2022, 44(2): 239-243. doi: 10.3969/j.issn.1002-2619.2022.02.014
[33]	吴戈, 陆雅席, 杨苹, 等. 基于网络药理学探讨加味柴胡疏肝散治疗冠心病伴焦虑/抑郁的作用机制[J]. 广西医学, 2023, 45(3): 309-316.
[34]	冠心病合理用药指南(第2版)[J]. 中国医学前沿杂志(电子版), 2018, 10(06): 1-130.
[35]	世界中医药联合会心血管病专业委员会, 中国中西医结合学会心血管病专业委员会, 中华中医药学会介入心脏病学会, 等. 冠状动脉血运重建术后心绞痛中西医结合诊疗指南[J]. 中国中西医结合杂志, 2020, 40(11): 1298-1307. doi: 10.7661/j.cjim.2020097.181
[36]	毛静远, 吴永健, 史大卓. 中成药治疗冠心病临床应用指南(2020年)[J]. 中西医结合心脑血管病杂志, 2021, 19(9): 1409-1435.
[37]	中国医师协会中西医结合医师分会心血管病专业委员会, 国家中医心血管病临床医学研究中心. 麝香保心丸治疗冠心病专家共识[J]. 中国中西医结合杂志, 2022, 42(7): 782-790.
[38]	《冠状动脉微血管病中西医结合诊疗指南》项目组. 冠状动脉微血管病中西医结合诊疗指南[J]. 中国中西医结合杂志, 2023, 43(9): 1029-1039.
[39]	《复方丹参滴丸临床应用专家共识》编写项目组. 复方丹参滴丸临床应用专家共识[J]. 中国中西医结合杂志, 2025, 45(5): 517-525.
[40]	邢晚秋. 三七丹参片通过调控VEGF/Cdc42信号通路促进血管生成改善心肌缺血的作用及机制研究[D]. 昆明医科大学, 2024.
[41]	郑秀琴, 陈昆昌, 王留宝, 等. 三七丹参片对大鼠急性缺血大脑及心肌的保护作用研究[J]. 云南中医中药杂志, 2000(5): 33-35.
[42]	黄娟, 杜扬, 徐翰, 等. 瓜蒌薤白半夏汤治疗胸痹心痛效果及安全性系统评价[J]. 山东医药, 2022, 62(20): 84-87. doi: 10.3969/j.issn.1002-266X.2022.20.021
[43]	解紫从, 何浩强, 高嘉良, 等. 涤痰汤加减治疗冠心病心绞痛有效性及安全性的Meta分析[J]. 中国临床保健杂志, 2021, 24(1): 33-38. doi: 10.3969/J.issn.1672-6790.2021.01.010
[44]	沈仲琪, 刘明阳, 董振飞. 基于网络药理学及分子对接探寻仲景瓜蒌薤白半夏汤治疗冠心病的活性成分及作用机制[J]. 时珍国医国药, 2022, 33(10): 2550-2553. doi: 10.3969/j.issn.1008-0805.2022.10.73
[45]	高诗雨, 董悦, 严晨涛, 等. 丹蒌片联合西药治疗冠心病的疗效及安全性Meta分析[J]. 世界中西医结合杂志, 2024, 19(2): 233-239.
[46]	吴茜, 侯信铮, 吕乾瑜, 等. 痰瘀同治法(丹蒌片)对动脉粥样硬化患者血管内皮功能的作用[J]. 中国实验方剂学杂志, 2025, 31(12): 168-175.
[47]	李增, 张明雪. 基于复方网络药理学和分子对接技术研究丹蒌片治疗冠心病的作用机制[J]. 辽宁中医杂志, 2023, 50(1): 120-124+222-224.
[48]	周盾, 凌家艳, 余浩, 等. 当归四逆汤合督脉灸治疗寒凝心脉型微血管性心绞痛疗效观察[J]. 中华中医药学刊, 2024, 42(10): 232-235.
[49]	刘嘉宁, 张雅萍. 枳实薤白桂枝汤联合西药治疗寒凝气滞兼痰瘀证不稳定型心绞痛临床研究[J]. 新中医, 2023, 55(20): 36-39.
[50]	王镕, 况春燕. 基于网络药理学和分子对接研究当归四逆汤治疗稳定型心绞痛的作用机制[J]. 河南中医, 2024, 44(12): 1880-1887.
[51]	何湛湛, 杨桢, 亓玉婕, 等. 枳实薤白桂枝汤现代药理作用研究进展[J]. 中国实验方剂学杂志, 2023, 29(6): 254-259.
[52]	De-hua L , Jin X , Yu-lan R , et al. Effectiveness and Safety of Acupoint Application of Guan Xin Su He Pill (冠心苏合丸) for Patients with Chronic Stable Angina Pectoris: A Multi-Center, Randomized Controlled Trial[J]. Chinese Journal of Integrative Medicine, 2021, 27(11): 838-845.
[53]	刘剑锋, 况春燕, 郭慧. 基于网络药理学方法和分子对接技术探讨冠心苏合丸治疗冠心病的有效成分及作用机制[J]. 山西中医药大学学报, 2023, 24(05): 547-554.
[54]	易鑫颖, 周宇轩, 彭添凤, 等. 生脉散治疗心系疾病及其作用机制[J]. 生命的化学, 2024, 44(08): 1376-1383.
[55]	江雨洁, 张湘卓, 张书萌, 等. 生脉散加减联合西药常规治疗冠心病心绞痛Meta分析[J]. 世界中医药, 2022, 17(20): 2885-2891. doi: 10.3969/j.issn.1673-7202.2022.20.010
[56]	王萍, 赵姿雯, 王丁丁, 等. 生脉饮的化学成分、药理作用和临床应用进展[J]. 天津中医药大学学报, 2024, 43(6): 565-570.
[57]	曹占鸿, 潘建衡, 李娜, 等. 生脉散现代药理作用及作用机制的研究进展[J]. 中国实验方剂学杂志, 2019, 25(22): 212-218.
[58]	王厚恩, 白文宇, 刘唤, 等. 生脉方的研究进展[J]. 中成药, 2019, 41(01): 151-159.
[59]	Zou J G , Zhang J , Jia Z H , et al. Evaluation of the traditional Chinese Medicine Shensongyangxin capsule on treating premature ventricular contractions: A randomized, double-blind, controlled multicenter trial[J]. Chinese medical journal, 2011, 124(1): 76-83.
[60]	CHEN Y, WANG L, LI Y, et al. Efficacy and safety of shensong yangxin capsules for persistent atrial fibrillation: A Systematic Review and meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2025, 16: 1620340.
[61]	谢俊大, 钟萌, 吴真. 参松养心胶囊的药理毒理与临床研究概况[J]. 中国药房, 2008(33): 2628-2631.
[62]	国家中医心血管病临床医学研究中心, 中国医师协会中西医结合医师分会, 《生脉类注射剂临床应用中国专家共识》编写组. 生脉类注射剂临床应用中国专家共识[J]. 中国中西医结合杂志, 2020, 40(12): 1430-1438.
[63]	原双兴, 丁友鹤, 范楗彪. 益气复脉注射液联合针灸辅治冠心病心绞痛气阴两虚型疗效观察[J]. 实用中医药杂志, 2024, 40(12): 2487-2489.
[64]	郭贺杰, 李雯, 张亚娜. 益气复脉注射液辅治不稳定型冠心病心绞痛临床观察[J]. 实用中医药杂志, 2025, 41(3): 550-552.
[65]	贾福运, 高晟玮, 张瑞, 等. 中药注射液联合常规西药治疗冠心病稳定型心绞痛的临床疗效及血液流变学影响的网状Meta分析[J]. 世界科学技术-中医药现代化, 2024, 26(3): 601-616.
[66]	纪青, 雷李美. 参脉注射液联合西药治疗冠心病合并慢性心力衰竭气阴两虚证临床研究[J]. 新中医, 2021, 53(24): 61-64.
[67]	王广艳, 腾名子, 朱君. 天王补心丹加减治疗心房颤动合并冠心病阴虚火旺证的临床观察[J]. 中国实验方剂学杂志, 2018, 24(17): 189-194.
[68]	许方雷, 胡有志. 天王补心丹治疗冠心病伴失眠症的临床观察[J]. 湖北中医杂志, 2013, 35(11): 53-54.
[69]	何俊明, 陈光, 李洪峥, 等. 炙甘草汤治疗心血管病方论新析及循证进展[J]. 中华中医药杂志, 2020, 35(3): 1365-1367.
[70]	常致博, 段楚涵, 汪晓妍, 等. 炙甘草汤的现代临床应用及作用机制研究进展 [J]. 中国实验方剂学杂志: 2025, 1-14.
[71]	王常普. 加用六味地黄丸加减治疗冠心病心绞痛30例[J]. 广西中医药, 2015, 38(4): 27-8.
[72]	李长月, 孙兰军. 孙兰军从肾论治冠心病经验[J]. 河南中医, 2011, 31(12): 1365-6.
[73]	童黄锦, 杨月东, 邓良英, 等. 六味地黄丸对肾阴虚型绝经后女性冠心病经皮冠状动脉介入治疗术后的临床研究[J]. 中国医院药学杂志, 2022, 42(14): 1469-1473.
[74]	葛昭, 杨志华, 刘春香, 等. 六味地黄丸在心血管疾病的应用价值及网络药理学多靶点效应价值研究进展[J]. 世界中医药, 2022, 17(12): 1783-1787.
[75]	霍嘉琪, 田厚泽, 张雅玲, 等. 芪苈强心胶囊对慢性心力衰竭合并冠心病患者的疗效观察[J]. 中华中医药学刊: 2025, 1-11.
[76]	吴楠. 芪苈强心胶囊治疗冠心病并发心力衰竭患者的疗效观察[J]. 辽宁中医杂志, 2025, 52(5): 133-136.
[77]	刘剑锋, 况春燕. 基于网络药理学和分子对接技术探讨芪苈强心胶囊治疗冠心病的有效成分及作用机制[J]. 山西中医药大学学报, 2023, 24(11): 1248-56.
[78]	Zhou X B, Miao J, Zhuang Q, et al. Meta-analysis on effect of Shenfu injection in treating angina pectoris[J]. Zhongguo Zhong Yao Za Zhi, 2016, 41(3): 536-40.
[79]	Wang X, Guo R, Guo Y, et al. Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI[J]. Am Heart J, 2023, 260: 9-17.
[80]	吴斌, 曹国胜, 陈林霖, 等. 经典名方参附方活性成分的药理作用及临床应用研究进展[J]. 湖北中医杂志, 2022, 44(12): 51-54.
[81]	Xu F F, Xie X F, Hu H Y, et al. Shenfu injection: A review of pharmacological effects on cardiovascular diseases[J]. Front Pharmacol, 2024, 15: 1279584.
[82]	杨发甲. 针灸治疗冠心病心绞痛的临床疗效观察[J]. 中西医结合心血管病电子杂志, 2021, 9(26): 33-5.
[83]	卢圣锋, 丁亚娟, 于美玲, 等. 电针减轻大鼠心肌缺血损伤的AMPKα-HDAC5-HIF-1α信号级联机制[J]. 中国针灸, 2018, 38(9): 978-83.
[84]	包宇, 彭广操, 周怡, 等. 中医适宜技术规范化治疗稳定型心绞痛研究进展[J]. 中华中医药杂志, 2024, 39(6): 2991-6.
[85]	彭晶晶, 董婧, 靳杨, 等. 储药罐改善稳定型心绞痛(气虚血瘀型)患者胸闷胸痛症状效果观察[J]. 北京中医药, 2021, 40(4): 360-364.
[86]	修英. 刺血拔罐治疗心血瘀阻型冠心病心绞痛的临床研究[J]. 中国实用医药, 2022, 17(10): 141-3.
[87]	何花, 谭畅. 通痹复律安心加减方联合耳穴压豆治疗冠心病心绞痛[J]. 吉林中医药, 2024, 44(11): 1309-13.
[88]	陈科, 张罗健, 万峰. 刮痧的现代研究与临床应用[J]. 中国民族民间医药, 2011, 20(4): 4-5+8.
[89]	陈灵兰. 铜砭刮痧对气滞血瘀型冠心病患者干预效果的研究 [D], 2024.
[90]	刘淑玲, 蔡海荣, 林黄果, 等. 速效救心丸联合穴位贴敷治疗心血瘀阻证稳定型心绞痛的疗效观察[J]. 时珍国医国药, 2019, 30(1): 138-139.
[91]	肖芳, 李鹏. 中医外治法治疗冠心病心绞痛的研究现状[J]. 新疆中医药, 2025, 43(1): 120-123.
[92]	庄梦梦, 朱林平, 赵美. 中医外治法治疗心脏康复的研究进展[J]. 云南中医中药杂志, 2024, 45(7): 73-79.
[93]	张文文. 中药熏洗配合穴位按摩对冠心病失眠患者的影响[J]. 中西医结合心血管病电子杂志, 2022, 10(16): 80-3.
[94]	袁丽霞, 丁荣晶. 中国心脏康复与二级预防指南解读[J]. 中国循环杂志, 2019, 34(S1): 86-90.
[95]	王丽, 韦卓, 赵新望, 等. 太极拳对稳定型冠心病合并失眠症患者睡眠质量及心肺功能的影响[J]. 广西中医药大学学报, 2025, 28(2): 13-6.
[96]	潘婷婷, 张泽. 八段锦治疗老年冠心病的中医理论内涵及作用机制[J]. 中西医结合心脑血管病杂志, 2024, 22(1): 100-3.
[97]	林梅兰, 王珊, 江芷珊, 等. 真武汤联合八段锦对老年冠心病患者心肺运动功能及生存质量的影响[J]. 广州医药, 2024, 55(12): 1470-1475.
[98]	Salmoirago-Blotcher E, Wayne P M, Dunsiger S, et al. Tai Chi Is a Promising Exercise Option for Patients With Coronary Heart Disease Declining Cardiac Rehabilitation [J]. J Am Heart Assoc, 2017, 6(10).
[99]	武琦, 林娟, 刘耀晨, 等. 基于网络药理学的三七传统功效作用机制研究[J]. 中草药, 2020, 51(14): 3717-3727.
[100]	石礼平, 张国壮, 刘丛盛, 等. 三七化学成分和药理作用研究概况及质量标志物的预测[J]. 中国中药杂志, 2023, 48(8): 2059-2067.
[101]	Xiao H, Liu S, Fang B, et al. Panax notoginseng saponins promotes angiogenesis after cerebral ischemia-reperfusion injury[J]. J ginseng res, 2024, 48(6): 592-602.
[102]	Cui X, Zhang L, Lin L, et al. Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cells[J]. Int immunopharmacol, 2024, 143(3): 113574.
[103]	Liu Z R, Song Y L, Ning S Q, et al. Mechanism of action of ginsenoside Rg_2 on diabetic retinopathy and angiogenesis based on YAP/TLRs pathway[J]. Zhongguo Zhong Yao Za Zhi, 2025, 50(6): 1659-69.
[104]	Wen C, Liao X, Ye X, et al. Pharmacokinetics and Biological Activities of Notoginsenoside R1: A Systematical Review[J]. Am J Chin Med, 2025, 53(1): 205-49.
[105]	Zhou P, Xie W, Luo Y, et al. Inhibitory Effects of Ginsenoside Rb1 on Early Atherosclerosis in ApoE-/- Mice via Inhibition of Apoptosis and Enhancing Autophagy [J]. Molecules, 2018, 23(11): null.
[106]	Chen L, Li X, Li C, et al. Chinese Herbal Cardiotonic Pill Stabilizes Vulnerable Plaques in Rabbits by Decreasing the Expression of Adhesion Molecules[J]. J cardiovasc pharm, 2016, 68(3): 215-22.
[107]	张梦, 萧闵, 蔡婷, 等. 三七皂苷R1调控Nrf2介导的铁死亡途径改善ApoE-/-小鼠动脉粥样硬化[J]. 中草药, 2024, 55(15): 5135-5144.
[108]	Chen Y, Lai F, Xu H, et al. Chinese herb pairs for cardiovascular and cerebrovascular diseases: Compatibility effects, pharmacological potential, clinical efficacy, and molecular mechanisms[J]. J Ethnopharmacol, 2025, 347(null): 119516.
[109]	Zheng Q, Wang T, Wang S, et al. The anti-inflammatory effects of saponins from natural herbs[J]. Pharmacol therapeut, 2025, 269(null): 108827.
[110]	Zhao C, Fu J, Wang Y, et al. Latest Evidence and Perspectives of Panax Notoginseng Extracts and Preparations for the Treatment of Cardiovascular Diseases[J]. J Cardiovasc Pharmacol, 2025, 85(4): 248-60.
[111]	Li D, Wu X, Qi X, et al. Engineering scutellarin biosynthesis in Artemisia annua[J]. Plant Cell Rep, 2025, 44(4): 79.
[112]	葛文秀, 罗云, 谢学恒, 等. 灯盏花乙素药理作用机制研究进展[J]. 中国实验方剂学杂志, 2020, 26(22): 193-200.
[113]	Dogra N K, Kumar S, Kumar D. Vernonia anthelmintica (L. ) Willd. : An ethnomedicinal, phytochemical, pharmacological and toxicological review[J]. J ethnopharmacol, 2020, 256(null): 112777.
[114]	Su Y, Fan X, Li S, et al. Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis[J]. Dis markers, 2022, 2022(null): 3058354.
[115]	Su Y, Fan X, Li S, et al. Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis[J]. Dis Markers, 2022, 2022: 3058354.
[116]	Nie S, Zhang S, Wu R, et al. Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases[J]. Front Pharmacol, 2024, 15(null): 1470879.
[117]	Zhang X, Yin T, Wang Y, et al. Effects of scutellarin on the mechanism of cardiovascular diseases: A review[J]. Front Pharmacol, 2023, 14(null): 1329969.
[118]	支英杰, 赵君, 赵晖, 等. 灯盏花素注射剂治疗不稳定型心绞痛的有效性和安全性: 随机对照试验的系统评价和Meta分析[J]. 中国中药杂志, 2018, 43(19): 3940-55.
[119]	储继红, 蒋宝平, 吴婷, 等. 灯盏花素对冠心病血瘀证大鼠血浆N1-甲基烟酰胺水平的影响[J]. 药学与临床研究, 2025, 33(1): 9-13.
[120]	Wang X F, Chen X, Tang Y, et al. The Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases [J]. Pharmaceuticals (Basel), 2022, 15(11): null.
[121]	Zhong Z, Liu J. [Triterpenes isolated from Poria cocos by derivazations][J]. Zhong Yao Cai, 2002, 25(4): 247-50.
[122]	Xie J, Wang Y Y, Li J X, et al. [Effect and mechanism of Poria cocos polysaccharides on myocardial cell apoptosis in rats with myocardial ischemia-reperfusion injury by regulating Rho-ROCK signaling pathway][J]. Zhongguo Zhong Yao Za Zhi, 2023, 48(23): 6434-41.
[123]	Lan Y, Luo F K, Yu Y, et al. [Heart failure: innovative understanding from traditional Chinese medicine (TCM) and treatment with classic TCM formulas][J]. Zhongguo Zhong Yao Za Zhi, 2024, 49(23): 6521-32.
[124]	Lan Y, Luo F K, Yu Y, et al. Coronary heart disease: innovative understanding from traditional Chinese medicine and treatment by classic formulas[J]. Zhongguo Zhong Yao Za Zhi, 2024, 49(13): 3684-92.
[125]	全毅恒, 上官晨虹, 陈琛. 天麻中酚类成分对心脑血管疾病的药理作用研究进展[J]. 中草药, 2022, 53(14): 4582-92.
[126]	Zhan H D, Zhou H Y, Sui Y P, et al. The rhizome of Gastrodia elata Blume - An ethnopharmacological review[J]. J ethnopharmacol, 2016, 189(null): 361-85.
[127]	于涵, 张俊, 陈碧清, 等. 天麻化学成分分类及其药理作用研究进展[J]. 中草药, 2022, 53(17): 5553-5564.
[128]	马建福, 王豆, 李涛, 等. 天麻及其有效成分对神经系统疾病的药理作用研究进展[J]. 中华中医药学刊, 2023, 41(1): 127-132.
[129]	卢丹, 王媛媛, 张宏方. 天麻有效成分分析及其抗心血管疾病药理作用研究进展[J]. 现代中西医结合杂志, 2023, 32(19): 2769-74.
[130]	Zhang Y, Wang S, Wu J, et al. Gastrodin mitigates aortic valve calcification by inhibiting glycolysis and histone lactylation through interfering with valve interstitial cells[J]. Front Pharmacol, 2025, 16(null): 1547716.
[131]	Li Y, Yu X, Liu Y, et al. Pharmacodynamic components and molecular mechanism of Gastrodia elata Blume in treating hypertension: Absorbed components, network pharmacology analysis, molecular docking and in vivo experimental verification[J]. J ethnopharmacol, 2025, 345(null): 119583.
[132]	Zhang Y, Han L, Ning Q, et al. Gastrodin attenuates hypercholesterolaemia through regulating the PCSK9/LDLR signalling pathway by suppressing HNF-1α and activating FoxO3a[J]. Phytomedicine, 2025, 142(null): 156778.
[133]	Du R, Guo Y, Zhong W, et al. Gastrodin alleviates myocardial infarction by inhibiting inflammation, and apoptosis and promoting endothelial cell proliferation[J]. Biochem Biophys Rep, 2025, 42(null): 102014.
[134]	Gong M Q, Lai F F, Chen J Z, et al. Traditional uses, phytochemistry, pharmacology, applications, and quality control of Gastrodia elata Blume: A comprehensive review [J]. J ethnopharmacol, 2024, 319(Pt 1): 117128.
[135]	Guo L, Cheng B X, Guo Q S, et al. [Effects of harvest and different processing methods on anti-thrombin activity of Poecilobdella manillensis][J]. Zhongguo Zhong Yao Za Zhi, 2016, 41(11): 2087-92.
[136]	韩瑾, 宋研博, 孙永康, 等. 水蛭药理作用及其在脑病中的应用[J]. 中华中医药学刊, 2024, 42(5): 147-150.
[137]	周豪, 张颖, 邓淦予, 等. 基于NF-κB通路探讨菲牛蛭对颈动脉损伤兔血管内皮的保护作用[J]. 现代中西医结合杂志, 2024, 33(21): 2937-2945.
[138]	Wu S, Zhou Y, Wang Y, et al. Therapeutic Potentials of Medicinal Leech in Chinese Medicine[J]. Am j chinese med, 2024, 52(4): 1027-51.
[139]	Hosseini M, Jadidi A, Derakhshan Barjoei M M, et al. Applications of leech therapy in medicine: A systematic review[J]. Front Med (Lausanne), 2024, 11(null): 1417041.
[140]	李洋, 韩雅玲. 2024欧洲心脏病学会慢性冠状动脉综合征管理指南解读[J]. 临床军医杂志, 2024, 52(9): 881-884.
[141]	罗芳, 王晓. 《2024 ESC慢性冠状动脉综合征管理指南》解读[J]. 临床心血管病杂志, 2024, 40(10): 795-797.
[142]	陈新谦, 金有豫, 汤光. 新编药物学 [M]. 北京: 人民卫生出版社, 2018.
[143]	Virani S S, Alonso A, Aparicio H J, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association[J]. Circulation, 2021, 143(8): e254-e743.
[144]	中国康复医学会心血管病专业委员会. 冠心病康复与二级预防中国专家共识[J]. 中华心血管病杂志, 2019, 47(10): 766-775.
[145]	张聪. 中国营养学会发布《中国居民膳食指南(2022)》[J]. 食品安全导刊, 2022(14): 4.
[146]	国家卫生健康委员会. 中国公民健康素养——基本知识与技能(2015年版)[M]. 北京: 人民卫生出版社, 2015.
[147]	殷磊. 护理学基础 [M]. 北京: 人民卫生出版社, 2017.

Relative Articles(20)

Relative Articles

[1]	Yuzhen ZHAO, Yingyan MA, Lili HE. Analysis of the Value of Serum Testosterone，Sex Hormone-Binding Globulin and Vitamin D Levels in Predicting Gestational Diabetes Mellitus Complicated by Polycystic Ovary Syndrome. Journal of Kunming Medical University,
[2]	Li ZHANG, Ying ZHANG, Yudong RAO, Xueya ZHANG, Zhuo YU. Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20250820
[3]	Xiaodong ZHANG, Nan NIU, Ying LIU, Jiajie MEI, Zhaohong GENG, Hongyan WANG. Effect of Nicorandil on Inflammation-related Markers after PCI Intervention in Patients with Acute Coronary Syndromes. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20240219
[4]	Jin-yun CAI, Juan WANG, Rui-xi SUN, Ping FU. Clinical Features of Rhupus Syndrome. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20210201
[5]	Xing LIU, Bing OUYANG, Na LI, Ji LUO, Xu-qin SHI, Jie CHEN, Hui SUN, Hai-wen LI. Effect and Economic Evaluation of the Combination of Traditional Chinese and Western Medicine in Treatment of MDR-TB. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20201106
[6]	Yuan Hai Feng , Su Xue Wen , Li Tian Chang . Correlative Analysis of the Onset Age of Acute Coronary Syndrome with Previous Diseases. Journal of Kunming Medical University,
[7]	Li Rui Jie . Risk-Treatment Paradox in Acute Coronary Syndrome. Journal of Kunming Medical University,
[8]	Li Xiao Fei . The Influence of the Integrated Traditional Chinese and Western Medicine Treatment on Serum Levels of TNF-α， IL-6 and Endotoxin of Patients with Hepatic Failure. Journal of Kunming Medical University,
[9]	Qing Yan Ping , Tan Shu , Zhu You Shan , Yang Shu Hua . Application of Integrative Medicines of TCM and WM Combined with Fast-track Surgery Concept in Perioperative Nursing in Colorectal Surgery. Journal of Kunming Medical University,
[10]	Li Wen Chang . Comparison of the Effect of Chinese and Western Medicine and Western medicine on Senile Osteoporosis. Journal of Kunming Medical University,
[11]	Hao Ying Lu . . Journal of Kunming Medical University,
[12]	Wei Wei . . Journal of Kunming Medical University,
[13]	Zhang Yan . . Journal of Kunming Medical University,
[14]	Li Xiao Ting . . Journal of Kunming Medical University,
[15]	Jiang Fan. . Journal of Kunming Medical University,
[16]	Li Jia Xiang . . Journal of Kunming Medical University,
[17]	. The Value of Ankle-brachial Index Combined with Brachial Ankle Pulse Wave Velocity in Patients with Acute Coronary Syndrome. Journal of Kunming Medical University,
[18]	. Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy. Journal of Kunming Medical University,
[19]	. The Application of Intraaortic Balloon Counterpulsation in Acute Coronary Syndrome. Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,